RXST
RxSight, Inc.
34.96
USD
This page is just a preview of the data found in TrendSpider’s full version
RxSight, Inc. stock is up 38.29% since 30 days ago. The next earnings date is Mar 4, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November. In the last 8 Unusual Options Trades, there were 4 CALLs, 4 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 25 Oct 19:03 | 17 Nov, 2023 | 25.00 | 1635 | ||
| 09 Nov 15:51 | 17 Nov, 2023 | 22.50 | 23 | ||
| 09 Nov 16:16 | 17 Nov, 2023 | 22.50 | 23 | ||
| 09 Nov 16:20 | 17 Nov, 2023 | 22.50 | 23 | ||
| 09 Nov 18:29 | 17 Nov, 2023 | 22.50 | 23 | ||
| 29 Nov 20:43 | 15 Dec, 2023 | 25.00 | 160 | ||
| 05 Dec 15:07 | 15 Dec, 2023 | 20.00 | 557 | ||
| 08 Dec 18:00 | 15 Mar, 2024 | 40.00 | 148 |
RxSight, Inc. engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. The company was formerly known as Calhoun Vision, Inc.
